Practical Barriers and Facilitators Experienced by Patients, Pharmacists and Physicians to the Implementation of Pharmacogenomic Screening in Dutch Outpatient Hospital Care—An Explorative Pilot Study

Pharmacogenomics (PGx) can provide optimized treatment to individual patients while potentially reducing healthcare costs. However, widespread implementation remains absent. We performed a pilot study of PGx screening in Dutch outpatient hospital care to identify the barriers and facilitators to implementation experienced by patients ( n = 165), pharmacists ( n = 58) and physicians ( n = 21). Our results indeed suggest that the current practical experience of healthcare practitioners with PGx is limited, that proper education is necessary, that patients want to know the exact implications of t... Mehr ...

Verfasser: Pauline Lanting
Evelien Drenth
Ludolf Boven
Amanda van Hoek
Annemiek Hijlkema
Ellen Poot
Gerben van der Vries
Robert Schoevers
Ernst Horwitz
Reinold Gans
Jos Kosterink
Mirjam Plantinga
Irene van Langen
Adelita Ranchor
Cisca Wijmenga
Lude Franke
Bob Wilffert
Rolf Sijmons
Dokumenttyp: Artikel
Erscheinungsdatum: 2020
Reihe/Periodikum: Journal of Personalized Medicine, Vol 10, Iss 293, p 293 (2020)
Verlag/Hrsg.: MDPI AG
Schlagwörter: pharmacogenetics / pharmacogenomics / implementation / screening / pre-emptive / personalized medicine / Medicine / R
Sprache: Englisch
Permalink: https://search.fid-benelux.de/Record/base-27018511
Datenquelle: BASE; Originalkatalog
Powered By: BASE
Link(s) : https://doi.org/10.3390/jpm10040293